Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-13

Clinical Trial Update: Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma [Phase 2]

View source ↗

Summary

A Phase 2 double-blind trial evaluated the efficacy of collagenase histolyticum for treating lipoma; results were posted in December 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • collagenase histolyticum (collagenase histolyticum)

Snippet

Sponsor: Gerut, Zachary, M.D. | Conditions: Lipoma | Phase 2 | Status: COMPLETED | Results posted: 2016-12-13